{"id":56745,"date":"2015-05-10T22:34:00","date_gmt":"2015-05-11T02:34:00","guid":{"rendered":"http:\/\/1boringoldman.com\/?p=56745"},"modified":"2015-05-11T00:11:16","modified_gmt":"2015-05-11T04:11:16","slug":"about-time-9","status":"publish","type":"post","link":"https:\/\/1boringoldman.com\/index.php\/2015\/05\/10\/about-time-9\/","title":{"rendered":"about time<sub>2<\/sub>&#8230;"},"content":{"rendered":"<br \/>\n<blockquote>\n<div align=\"center\" class=\"big\"><a href=\"http:\/\/www.bmj.com\/content\/350\/bmj.h2373\" target=\"_blank\">The BMJ requires data sharing on request for all trials<\/a><\/div>\n<div align=\"center\" class=\"small\">by Elizabeth Loder and Trish&nbsp; Groves<\/div>\n<div align=\"center\" class=\"middle\"><strong><font color=\"#0066ff\">British Medical Journal<\/font><\/strong>. 2015 350:h2373<\/div>\n<p align=\"justify\">Heeding calls from the Institute of Medicine, WHO, and the Nordic Trial Alliance, we are extending our policy. The  movement to make data from clinical trials widely accessible has  achieved enormous success, and it is now time for medical journals to  play their part. From 1 July <em>The BMJ<\/em> will extend its  requirements for data sharing to apply to all submitted clinical trials,  not just those that test drugs or devices. The data transparency revolution is gathering pace.<a href=\"http:\/\/www.bmj.com\/content\/350\/bmj.h2373#ref-2\">2<\/a>  Last month, the World Health Organization [WHO] and the Nordic Trial  Alliance released important declarations about clinical trial  transparency.<\/p>\n<p align=\"justify\">These  announcements come on the heels of the US Institute of Medicine&rsquo;s [IOM]  report on sharing clinical trial data, which called for a  transformation of existing scientific culture to one where &ldquo;data sharing  is the expected norm.&rdquo;  The efforts of industry, too, must be acknowledged, some of which  caught many people by surprise. In particular, Medtronic&rsquo;s cooperation  with the Yale University Open Data project and GlaxoSmithKline&rsquo;s  leadership on data disclosure efforts stand out.<\/p>\n<p align=\"justify\">WHO&rsquo;s  statement on public disclosure of clinical trial results and the  accompanying rationale reiterate the organisation&rsquo;s support for  registration of clinical trials.  WHO declares that the main results of clinical trials should be posted  on a clinical trial registry or other acceptable website and submitted  for journal publication within a year of study completion. The  expectation is that results will be &ldquo;made available publicly at most  within 24 months of completion.&rdquo; The statement does not call for  mandatory sharing of primary data from trials but instead &ldquo;encourages&rdquo;  sharing of research datasets &ldquo;whenever appropriate.&rdquo;<\/p>\n<div align=\"justify\">In a move that is particularly welcomed by Ben Goldacre, cofounder of the AllTrials campaign,  WHO also recommends disclosure of previously conducted but unreported  clinical trials in a searchable and free registry and says it is  &ldquo;desirable&rdquo; that these trials should be published in a peer reviewed  journal. Goldacre notes that this is important because &ldquo;the overwhelming  majority of prescriptions today are for treatments that came onto the  market &mdash; and were therefore researched &mdash; over the preceding decades rather  than the past five years&rdquo;&#8230;<\/div>\n<\/blockquote>\n","protected":false},"excerpt":{"rendered":"<p>The BMJ requires data sharing on request for all trials by Elizabeth Loder and Trish&nbsp; Groves British Medical Journal. 2015 350:h2373 Heeding calls from the Institute of Medicine, WHO, and the Nordic Trial Alliance, we are extending our policy. The movement to make data from clinical trials widely accessible has achieved enormous success, and it [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[5],"tags":[],"class_list":["post-56745","post","type-post","status-publish","format-standard","hentry","category-opinion"],"_links":{"self":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/56745","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/comments?post=56745"}],"version-history":[{"count":5,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/56745\/revisions"}],"predecessor-version":[{"id":56750,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/56745\/revisions\/56750"}],"wp:attachment":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/media?parent=56745"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/categories?post=56745"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/tags?post=56745"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}